Eamon Dreisbach

Philadelphia

Managing Editor at Healio

Proud fan of small animals, environmentalism and condiment packets with tear away corners

Featured in: Favicon

healio.com Favicon

japantimes.co.jp Favicon

temple-news.com

Articles

VIDEO: Gildeuretinol meets endpoint in Stargardt disease study

1 month ago | healio.com | Benjamin Bakall |Alex Young |Eamon Dreisbach |Anthony DeFino

SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, Benjamin Bakall, MD, PhD, discusses 2-year data from the TEASE-1 study investigating the safety and efficacy of gildeuretinol in patients with Stargardt disease. The study met its primary endpoint, and patients who received gildeuretinol (Alkeus Pharmaceuticals) showed a significant reduction in growth of the area of atrophy.
VIDEO: No difference seen in RG, RGB imaging in assessing diabetic retinopathy severity

1 month ago | healio.com | Alex Young |Eamon Dreisbach |Anthony DeFino

SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, Paolo S. Silva, MD, discusses a study comparing ultrawide field red-green vs. red-green-blue imaging for determining the severity of diabetic retinopathy. “Based on our study of 95 eyes in 47 patients, we’ve seen that there is virtually no difference in the RG and RGB imaging devices in its ability to predict and identify the severity of retinopathy present in these eyes,” he said.
AI model shows potential for predicting glaucomatous eyes

1 month ago | healio.com | Eamon Dreisbach

Key takeaways: A multimodal AI model determined if eyes were healthy, glaucomatous or glaucoma suspected. The model combined image and parameter data to make its predictions. SALT LAKE CITY — Multimodal AI models may be useful to predict glaucomatous status of eyes, according to a poster presentation at the Association for Research in Vision and Ophthalmology meeting.
3-year data shows positive vision, fluid status maintenance for faricimab in wet AMD

1 month ago | healio.com | Eamon Dreisbach

Key takeaways:Data from patients with wet AMD who received nine injections of faricimab were analyzed. Study results suggested rapid improvements in anatomy in both previously treated and treatment-naïve patients. SALT LAKE CITY — Faricimab demonstrated “rapid improvements” in anatomic features across previously treated and treatment-naïve patients, according to 3-year study results.
Presbyopia-correcting IOL demonstrates good visual acuity in light, dark settings

2 months ago | healio.com | Eamon Dreisbach

Key takeaways:Patients reported high satisfaction with the Tecnis Odyssey IOL. Most patients were not bothered by most visual disturbances. LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in low light environments, according to a study. “We know our patients require spectacle independence, and their requirements are getting more robust as our technology tries to keep pace.
Richard L. Lindstrom, MD, inducted into ASCRS Ophthalmology Hall of Fame

2 months ago | healio.com | Eamon Dreisbach

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Patients with irregular astigmatism candidates for topography-guided excimer ablation

2 months ago | healio.com | Eamon Dreisbach

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
VIDEO: Gene therapy shows promise for treatment of wet AMD

Mar 6, 2025 | healio.com | Allen Ho |Anthony DeFino |Eamon Dreisbach

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses recent breakthroughs demonstrating that gene therapy is a viable option for treating wet age-related macular degeneration. According to Ho, gene therapies administered intravitreally or in the subretinal space can effectively deliver transgenes and spur the growth of therapeutic proteins. “We have really strong evidence from multiple programs ...
VIDEO: Macular telangiectasia type 2 cell therapy shows promising 9-year data

Mar 6, 2025 | healio.com | Mark Gillies MD |Anthony DeFino |Eamon Dreisbach

January 27, 2025 3 min watch VIDEO: Macular telangiectasia type 2 cell therapy shows promising 9-year data Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Retina/Vitreous in Ophthalmology. Subscribe Added to email alerts You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published.
Evaluation of OCT, uveitis history useful during patient selection for GA therapeutics

Mar 6, 2025 | healio.com | Eamon Dreisbach |Nancy Hemphill

Key takeaways: Careful evaluation of imaging is important when deciding who to treat with approved geographic atrophy drugs. Fellow eye status and ellipsoid zone integrity are also key factors. KOLOA, Hawaii — Assessing fellow eye status, age and history of uveitis are helpful ways to determine which patients are most likely to benefit from treatment with FDA-approved drugs for geographic atrophy, according to a speaker. “What I do stress is looking at the lesion growth of prior photographs.